Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
- PMID: 35701778
- PMCID: PMC9195328
- DOI: 10.1186/s12905-022-01824-9
Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
Abstract
Background: Preoperative anemia affects perioperative outcomes and often causes fatigue and psychological disorders. Therefore, anemia should be treated before a patient undergoes surgery. Ninjin'yoeito (NYT), a Japanese Kampo medicine composed of ginseng and Japanese angelica root with the other 10 herbs, is administered for anemia, fatigue and anxiety; however, there are a few reports that have prospectively examined the effects of NYT before surgery for gynecological diseases. Hence, we tended to investigate its efficacy and safety.
Methods: In this open-label randomized trial, women with gynecological diseases accompanied by preoperative anemia (defined as < 11.0 g/dL Hemoglobin [Hb]) were randomly assigned (1:1) into the iron supplementation and NYT groups. Patients of the iron supplementation group and the NYT group received 100 mg/day iron supplementation with and without NYT (7.5 g/day) for at least 10 days before surgery. The primary endpoint was improvement in Hb levels before and after treatment, and Cancer Fatigue Scale (CFS) and Visual Analogue Scale for Anxiety (VAS-A) scores between groups. Statistical analyses were performed with Wilcoxon signed rank test, Wilcoxon rank sum test, and Fisher's exact test as appropriate.
Results: Forty patients were enrolled of whom 30 patients were finally analyzed after allocating 15 to each group. There was no difference in the characteristics between both groups. Hb significantly increased in both groups (iron supplementation group, 9.9 ± 0.8 g/dL vs. 11.9 ± 1.6 g/dL; NYT group, 9.8 ± 1.0 g/dL vs. 12.0 ± 1.0 g/dL); the difference in the elevations in Hb between both groups was statistically insignificant (P = 0.72). Contrarily, CFS (17.9 ± 10.2 vs. 8.1 ± 5.2) and VAS-A (56 mm (50-70) vs. 23 mm (6-48)) scores were significantly decreased only in the NYT group and these changes were greater in the NYT group (∆CFS, P = 0.015; ∆VAS-A, P = 0.014). Liver dysfunction occurred in one patient of the NYT group.
Conclusions: For treating preoperative anemia in women with gynecological conditions, NYT administration along with iron supplementation safely and efficiently improved the preoperative fatigue and anxiety in addition to the recovery from anemia.
Trial registration: jRCT1051190012 (28/April/2019, retrospectively registered).
Keywords: Anemia; Anxiety; Fatigue; Ferritin; Herbal medicine; Iron deficiency; Ninjin'yoeito.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
A quasi-randomized controlled trial of Ninjin'yoeito for the treatment of postpartum anemia and the prevention of postpartum depression.J Obstet Gynaecol Res. 2022 Nov;48(11):2830-2838. doi: 10.1111/jog.15378. Epub 2022 Jul 26. J Obstet Gynaecol Res. 2022. PMID: 35882511 Clinical Trial.
-
A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.Neuropeptides. 2021 Oct;89:102178. doi: 10.1016/j.npep.2021.102178. Epub 2021 Jul 7. Neuropeptides. 2021. PMID: 34298370
-
Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.J Altern Complement Med. 2020 Aug;26(8):750-757. doi: 10.1089/acm.2020.0083. Epub 2020 Jun 17. J Altern Complement Med. 2020. PMID: 32551796 Clinical Trial.
-
Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2019 Sep 2;2019:9590260. doi: 10.1155/2019/9590260. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31565066 Free PMC article. Review.
-
Ninjin'yoeito, a herbal medicine, enhances glucose tolerance in mice.Neuropeptides. 2021 Aug;88:102150. doi: 10.1016/j.npep.2021.102150. Epub 2021 Apr 16. Neuropeptides. 2021. PMID: 33895618 Review.
Cited by
-
Topological Data Analysis of Ninjin'yoeito Effects Unraveling Complex Interconnections in Patients With Frailty: A Pilot Study.Cureus. 2024 Nov 30;16(11):e74855. doi: 10.7759/cureus.74855. eCollection 2024 Nov. Cureus. 2024. PMID: 39737299 Free PMC article.
-
Renshen Yangrong decoction for secondary malaise and fatigue: network pharmacology and Mendelian randomization study.Front Nutr. 2024 Jun 20;11:1404123. doi: 10.3389/fnut.2024.1404123. eCollection 2024. Front Nutr. 2024. PMID: 38966421 Free PMC article.
-
The beneficial potential of ginseng for menopause.J Ginseng Res. 2024 Sep;48(5):449-453. doi: 10.1016/j.jgr.2024.05.008. Epub 2024 May 31. J Ginseng Res. 2024. PMID: 39263310 Free PMC article. Review.
-
Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.Cureus. 2023 Jun 21;15(6):e40767. doi: 10.7759/cureus.40767. eCollection 2023 Jun. Cureus. 2023. PMID: 37363115 Free PMC article.
-
Ginseng and Ginseng Herbal Formulas for Symptomatic Management of Fatigue: A Systematic Review and Meta-Analysis.J Integr Complement Med. 2023 Aug;29(8):468-482. doi: 10.1089/jicm.2022.0532. Epub 2023 Feb 1. J Integr Complement Med. 2023. PMID: 36730693 Free PMC article.
References
-
- World Health Organization (WHO). Anaemia. WHO Health topics. Available on https://www.who.int/health-topics/anaemia. Accessed 18 April 2022.
-
- Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396–1407. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous